Diagnosed prevalent cases of T1D in France projected to increase by 44% over next decade, says GlobalData

Diagnosed prevalent cases of type 1 diabetes (T1D) in the eight major markets (8MM*) combined are expected to increase from 3.33 million cases in 2019 to 3.92 million in 2029, at an annual growth rate (AGR) of 1.77%, according to GlobalData, a leading data and analytics company.

Of the 8MM, the diagnosed prevalent cases of T1D in France are expected to grow at an AGR of 4.40% (2019–2029), followed by Canada (3.80%) and the US (3.53%).

GlobalData’s latest report, ‘Type 1 Diabetes – Epidemiology Forecast to 2029’, notes that the major drivers for the upward trend of diagnosed prevalent cases of T1D in the 8MM over the next decade are changing population demographics and the trend analysis in the US, Germany, Italy, Spain, UK, Japan, and Canada. The diagnosed prevalence of T1D is also correlated with the risk factors associated with the condition, specifically genetic and environmental factors such as a family history, seasonal variations, breast feeding, a history of infectious diseases and psychological disorders.

Suneedh Manthri, Associate Project Manager of Epidemiology at GlobalData, comments: “T1D, formerly referred to as insulin-dependent diabetes, is one of the most common chronic diseases in childhood worldwide. Given the fact that the condition typically affects individuals early in life, diagnosis at an early age is the key factor in preventing or delaying the negative complications of the condition, as poor management of the condition can lead to life-threatening complications later in life.

“As there is currently no curative treatment available for T1D, continuous proper management of the condition, which includes early detection, insulin injections, dietary management, therapeutic exercise, and self-monitoring of blood glucose levels, is essential to maintaining the activities of daily living in those affected.”

*8MM: US, France, Germany, Italy, Spain, UK, Japan, and Canada

More Media